Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)
22.97
-0.30 (-1.29%)
Mar 26, 2026, 11:30 AM CST
SHA:600332 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 14,940 | 18,273 | 21,309 | 22,500 | 22,377 |
Short-Term Investments | 8,861 | 4,446 | 729.16 | 2,117 | - |
Trading Asset Securities | 4 | - | 4 | 56.87 | - |
Cash & Short-Term Investments | 23,805 | 22,719 | 22,042 | 24,673 | 22,377 |
Cash Growth | 4.78% | 3.07% | -10.66% | 10.26% | 14.61% |
Accounts Receivable | 20,940 | 19,456 | 19,598 | 19,168 | 17,211 |
Other Receivables | 1,186 | 993.65 | 882.35 | 920.51 | 1,276 |
Receivables | 22,126 | 20,449 | 20,480 | 20,088 | 18,486 |
Inventory | 13,138 | 12,812 | 11,507 | 10,672 | 10,438 |
Other Current Assets | 2,449 | 1,782 | 1,955 | 1,631 | 1,510 |
Total Current Assets | 61,518 | 57,762 | 55,984 | 57,064 | 52,811 |
Property, Plant & Equipment | 8,365 | 7,939 | 7,516 | 6,570 | 5,684 |
Long-Term Investments | 8,793 | 10,146 | 9,452 | 5,897 | 2,891 |
Goodwill | 834.09 | 830.85 | 829.47 | 829.47 | 829.47 |
Other Intangible Assets | 3,181 | 2,829 | 2,886 | 2,585 | 2,582 |
Long-Term Deferred Tax Assets | 1,286 | 1,210 | 1,164 | 865.34 | 794.23 |
Long-Term Deferred Charges | 162.47 | 558.49 | 499.77 | 407.47 | 143.05 |
Other Long-Term Assets | 370.9 | 407.77 | 256.22 | 446.54 | 382.46 |
Total Assets | 84,511 | 81,684 | 78,587 | 74,665 | 66,118 |
Accounts Payable | 17,571 | 16,320 | 15,686 | 14,961 | 14,733 |
Accrued Expenses | 3,569 | 3,673 | 3,651 | 3,484 | 3,478 |
Short-Term Debt | 9,860 | 9,123 | 7,799 | 9,146 | 8,428 |
Current Portion of Long-Term Debt | 2,027 | 1,332 | 36.45 | 498.58 | 30.03 |
Current Portion of Leases | 185.2 | 190.57 | 213.38 | 208.15 | 215.77 |
Current Income Taxes Payable | 170.9 | 118.4 | 249.26 | 237 | 143.41 |
Current Unearned Revenue | 2,833 | 5,072 | 5,430 | 5,644 | 2,740 |
Other Current Liabilities | 2,909 | 3,088 | 3,170 | 3,216 | 2,485 |
Total Current Liabilities | 39,125 | 38,916 | 36,235 | 37,395 | 32,254 |
Long-Term Debt | 3,174 | 2,806 | 3,324 | 1,639 | 752.81 |
Long-Term Leases | 371.47 | 445.72 | 578.19 | 545.84 | 497.7 |
Long-Term Unearned Revenue | 1,042 | 1,002 | 1,001 | 930.93 | 826.86 |
Pension & Post-Retirement Benefits | 0.29 | 0.3 | 0.29 | 0.32 | 0.3 |
Long-Term Deferred Tax Liabilities | 599.37 | 625.56 | 639.53 | 394.59 | 331.73 |
Other Long-Term Liabilities | 116.74 | 119.31 | 130.6 | 121.45 | 127.87 |
Total Liabilities | 44,428 | 43,914 | 41,909 | 41,027 | 34,791 |
Common Stock | 1,626 | 1,626 | 1,626 | 1,626 | 1,626 |
Additional Paid-In Capital | 10,324 | 10,114 | 10,106 | 10,106 | 9,957 |
Retained Earnings | 25,861 | 24,179 | 23,212 | 20,347 | 17,497 |
Comprehensive Income & Other | -22.6 | -13.84 | -24.34 | -12.9 | -17.48 |
Total Common Equity | 37,788 | 35,905 | 34,919 | 32,065 | 29,062 |
Minority Interest | 2,295 | 1,865 | 1,759 | 1,573 | 2,264 |
Shareholders' Equity | 40,083 | 37,770 | 36,678 | 33,638 | 31,327 |
Total Liabilities & Equity | 84,511 | 81,684 | 78,587 | 74,665 | 66,118 |
Total Debt | 15,617 | 13,897 | 11,951 | 12,038 | 9,924 |
Net Cash (Debt) | 8,188 | 8,823 | 10,091 | 12,635 | 12,453 |
Net Cash Growth | -7.20% | -12.57% | -20.14% | 1.47% | 24.99% |
Net Cash Per Share | 5.04 | 5.43 | 6.21 | 7.77 | 7.66 |
Filing Date Shares Outstanding | 1,626 | 1,626 | 1,626 | 1,626 | 1,626 |
Total Common Shares Outstanding | 1,626 | 1,626 | 1,626 | 1,626 | 1,626 |
Working Capital | 22,394 | 18,847 | 19,748 | 19,669 | 20,557 |
Book Value Per Share | 23.24 | 22.08 | 21.48 | 19.72 | 17.88 |
Tangible Book Value | 33,773 | 32,245 | 31,203 | 28,651 | 25,650 |
Tangible Book Value Per Share | 20.77 | 19.83 | 19.19 | 17.62 | 15.78 |
Buildings | 6,464 | 5,213 | 4,328 | 3,630 | 3,317 |
Machinery | 5,521 | 5,106 | 4,416 | 4,025 | 3,582 |
Construction In Progress | 1,150 | 1,846 | 2,405 | 2,108 | 1,564 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.